Boehringer Ingelheim reviews £20 million media account

LONDON - Boehringer Ingelheim, the Germany-based pharmaceuticals company, is reviewing its estimated £20 million global media planning and buying account.

Boehringer…reviewing media business
Boehringer…reviewing media business

Boehringer, which is best known for its Pharmaton vitamins and Bisolvon cough syrup brands, uses a variety of agencies across different markets and has invited major media networks to pitch for the global business.

It has sent initial requests for information to networks and is expected to draw up a pitchlist of agencies to contest the business later this month.

The company handed the launch account for Flibanserin, a treatment for decreased libido in premenopausal women, to PAN Advertising and Delaney Lund Knox Warren last year.

PAN was awarded the trade side of the account with DLKW handling the consumer market portion. The two agencies have responsibility for the Healthcare Professional launch and consumer disease awareness campaigns for Flibanserin. Boehringer's 2008 results showed that it is outpacing growth in the general pharmaceutical industry.

Become a member of Campaign from just £51 a quarter

Get the very latest news and insight from Campaign with unrestricted access to campaignlive.co.uk ,plus get exclusive discounts to Campaign events

Become a member

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an alert now

Partner content